Peter S. Rabinovitch, M.D. Distinguished Alumnus Award
July 22, 2019 in Research
Dr. Peter Rabinovitch talks about his life long connection with the University of Washington and his research in the Biology of Aging.
Exploring the puzzle of Alzheimer’s ‘in a dish’ - Young Lab
August 28, 2018 in Research
Jessica Young, PhD, Assistant Professor of Pathology, studies the molecular and cellular mechanisms behind late-onset sporadic Alzheimer’s disease (SAD), the most common neurodegenerative disorder. The Young Lab's work is featured in an article on the UW Medicine Huddle and Newsroom websites.
Inventing a Blood Test for Early Detection of Alzheimer’s and Parkinson’s Diseases - Zhang Lab
August 06, 2018 in Research
The Zhang Lab, led by Dr. Jing Zhang, MD, PhD, Professor of Pathology at UW Medicine, is aiming to be the first group to develop reliable, accurate, and reproducible blood biomarkers in the field for Alzheimer’s and Parkinson’s diseases. The Zhang Lab's work is featured on the UW Medicine Memory and Brain Wellness Center website.
Commentary: Rare-disease research benefits us all
April 26, 2018 in Research, Newsletter
Case in point: A drug for cancer was found to extend lives of people with progeria, and may have broader use in cardiovascular health.
Herpes Hypothesis Leads to Surprise Cancer-Related Finding
February 16, 2018 in Research
Dr. Jia Zhu's herpes research may have implications for new therapies in cancer applications.
AAAS names 8 UW researchers as fellows in 2017
November 27, 2017 in Research, Newsletter
Eight University of Washington researchers are among the 396 new fellows of the American Association for the Advancement of Science, announced this month. Election as a fellow of AAAS is an honor bestowed upon members by their peers.
Call for ADRC Pilot Project Proposals
September 20, 2017 in Research
The UW Alzheimer's Disease Reseach Center seeks proposals for pilot projects that use its resources to advance the understanding, diagnosis, and/or treatment of Alzheimer’s disease. Click on View Website to find out more.
Ninety-nine percent of ailing NFL player brains show hallmarks of neurodegenerative disease
September 05, 2017
The largest study of its kind has found damage in the vast majority of former football players’ brains donated for research after they developed mental symptoms during life. Of 202 former players of the U.S. version of the game whose brains were examined, 87% showed the diagnostic signs of chronic traumatic encephalopathy (CTE), a neurodegenerative disease associated with repetitive head trauma. Among former National Football League (NFL) players in the sample, that number jumped to 99%. The findings will likely ratchet up the pressure on leaders at all levels of football to protect their players. Still, the authors and other experts caution against overinterpreting the results, because the brains all came from symptomatic former players and not from those who remained free of mental problems.
Congresswoman DelBene Visit Turns Spotlight on Role of NIH, Medicare/Medicaid Funding
September 05, 2017
Congresswoman Suzan DelBene (WA-01) toured our Alzheimer's Disease Research Center, including the neuropathology core that is run by Dr. Keene. This article nicely highlights the service that the neuropathology core provides as part of our flagship Alzheimers Disease Research Center.
The George Martin-Dennis Reichenbach Endowment in Pathology
July 05, 2017 in Education, Research
Join us in honoring George Martin and Dennis Reichenbach’s deep and lasting commitment to research, education, and the development of new leaders for the discipline of pathology. No depiction of the strength of our department would be complete without noting the impact Dennis and George have had on generations of graduate students, post-doctoral students, and junior faculty. By supporting the George Martin-Dennis Reichenbach Endowment, you are not only honoring the amazing impact of two exceptional scientists, you are enabling early career pathologists to pursue their research interests that fall outside of the traditional focus areas of federal funding programs. In the spirit of the indelible impact Drs. Martin and Reichenbach continue to have on our field, this endowment’s purpose is to foster innovative research and better inform our fight against disease.